HEXO Corp Announces Downward Revision to its Proposed Share Consolidation Ratio
HEXO Corp (NYSE:HEXO) announced an amendment to its share consolidation plan ahead of the annual meeting on December 11, 2020. The consolidation ratio has been revised from eight old common shares for one new share to four for one, aiming to increase the share price to comply with NYSE standards. The company cites improved market conditions and a positive outlook for its growth strategy, particularly in Canadian beverage and recreational cannabis markets. HEXO aims to balance its share liquidity while regaining compliance with minimum share price requirements to avoid de-listing.
- Revised consolidation ratio from 8:1 to 4:1 demonstrates confidence in market recovery.
- HEXO maintains strong market presence in Canada, leading in beverages and improving sales momentum.
- Gap in sales rankings is narrowing with third-place competitor, indicating growth potential.
- Consolidation is necessary to regain compliance with NYSE's $1.00 minimum share price standard, indicating potential financial distress.
OTTAWA, Dec. 07, 2020 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE:HEXO) announces that it has made an amendment (the “Amendment”) to its notice of meeting dated October 28, 2020 (the “Notice of Meeting”) and its management information circular dated October 28, 2020 (the “Circular”) in respect of its annual and special meeting of shareholders scheduled to be held on December 11, 2020 (the “Meeting”).
The Notice of Meeting and the Information Circular provided that, at the Meeting, shareholders of the Company (“Shareholders”) would be asked to consider, and if deemed advisable, pass a special resolution authorizing and approving a consolidation of the outstanding common shares of the Company (“Common Shares”) on the basis of eight (8) old Common Shares for one (1) new Common Share, all as more particularly described in the Circular (the “Original Consolidation Ratio”). The purpose of the consolidation is to increase the Company's common share price to regain compliance with the US
“We believe that our solid financial position and the execution of our growth strategy is not yet reflected in our market valuation. We are number one in Canada in key categories such as beverages and have continued to gain sales momentum in critical markets including Ontario and Alberta. We are currently sitting fourth in recreational cannabis sales in Canada, with the gap between us and third place narrowing, while the gap between us and those behind us has widened”, said Sébastien St-Louis, HEXO CEO and co-founder. “Given the necessity to regain compliance with the US
The Amendment will be filed under the Company’s profiles on SEDAR and EDGAR and will also be available at https://docs.tsxtrust.com/2092, the notice-and-access website for the proxy materials for the Meeting maintained by the Company’s transfer agent and registrar, and can also be obtained from the Company upon request. The Company will not distribute an amended form of proxy in light of the proxy submission deadline of 10:00 a.m. (EST) on December 9, 2020, the fact that the amendment to the consolidation ratio is a downward revision and because the form of proxy confers discretionary authority with respect to amendments or variations to the matters identified in the Notice of Meeting or other matters which may properly come before the Meeting or any adjournment or postponement thereof. The persons named in the form of proxy for the Meeting intend to vote FOR the consolidation of the Common Shares at the New Consolidation Ratio unless the shareholder delivering the proxy has specified in the form of proxy that the Common Shares represented by such form of proxy are to be voted against such resolution.
About HEXO
HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis and Original Stash brands, and the medical market under HEXO medical cannabis. For more information please visit hexocorp.com.
Forward Looking Statements
This press release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are based on certain expectations and assumptions and are subject to known and unknown risks and uncertainties and other factors that could cause actual events, results, performance and achievements to differ materially from those anticipated in these forward-looking statements. Forward-looking statements should not be read as guarantees of future performance or results. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.
Investor Relations:
invest@HEXO.com
www.hexocorp.com
Media Relations:
(819) 317-0526
media@hexo.com
FAQ
What is HEXO Corp's new consolidation ratio?
Why is HEXO Corp consolidating its shares?
What are the implications of the share consolidation for HEXO shareholders?